On Sunday, 24 November, Frederik De Smet, our project coordinator, delivered an engaging lecture at KU Leuven’s Health Sciences Campus Gasthuisberg during Science day. He shared his work on immunotherapy and glioblastoma treatments. This was also a great opportunity to show how the GLIOMATCH project leverages immunotherapy and precision medicine to improve outcomes for adults and children with brain tumours.
Visit our photo gallery for more pictures from the event.
GLIOMATCH coordinator Prof. Frederik De Smet presented how the project connects tumour tissue, imaging and clinical data to understand responses to immunotherapy and support precision oncology for patients with brain tumours.
In this episode of the GLIOMATCH: Explained video series, Dr. Kathrin Cresswell, Professor of Digital Innovations in Health and Care at the University of Edinburgh, explains how GLIOMATCH is working to ensure the successful use and implementation of its novel data platform. We’ve summarised the interview in this news piece.
On World Brain Tumour Day 2026, GLIOMATCH participated in the European event “Advancing Brain Cancer Research: From policy action to scientific breakthroughs” at the European Parliament in Strasbourg. The event highlighted the urgent need to accelerate brain cancer research, strengthen European collaboration and turn scientific progress into improved care for patients.
The KU Leuven team attended EANO 2026 in Rome and Chiara Caprioli and Frederik De Smet presented glioblastoma research and a patient-derived brain tumour model. Discover highlights from the conference.
